Showing 161 - 180 results of 212 for search '"Cancer Medicine"', query time: 0.03s Refine Results
  1. 161
    Expression of MxA in esophageal cancer cell lines can influence sensitivity to chemotherapeutic agents but this does not require apoptosis

    Expression of MxA in esophageal cancer cell lines can influence sensitivity to chemotherapeutic agents but this does not require apoptosis by R. M. Hayes, T. R. O'Donovan, S. L. McKenna

    Published 2024-09-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 162
    The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer

    The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer by Si Chen, Caihong Yao, Na Tian, Chunying Zhang, Yuemei Chen, Xuting Wang, Yue Jiang, Tonghao Zhang, Tingting Zeng, Yali Song

    Published 2024-09-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 163
    Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival

    Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival by Jared R. Robbins, Ryan K. Schmid, Abdulrahman Y. Hammad, Thomas Clark Gamblin, Beth A. Erickson

    Published 2019-03-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 164
    Preclinical evaluation of avutometinib and defactinib in high‐grade endometrioid endometrial cancer

    Preclinical evaluation of avutometinib and defactinib in high‐grade endometrioid endometrial cancer by Tobias Max Philipp Hartwich, Miranda Mansolf, Cem Demirkiran, Michelle Greenman, Stefania Bellone, Blair McNamara, Shuvro P. Nandi, Ludmil B. Alexandrov, Yang Yang‐Hartwich, Silvia Coma, Jonathan Pachter, Alessandro D. Santin

    Published 2024-09-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 165
    A predictive risk‐scoring model for survival prognosis of multiple myeloma based on gain/amplification of 1q21: Experience in a tertiary hospital in South‐Western China

    A predictive risk‐scoring model for survival prognosis of multiple myeloma based on gain/amplification of 1q21: Experience in a tertiary hospital in South‐Western China by Yanqiu Xiong, Shanshan Liang, Wenjiao Tang, Li Zhang, Yuhuan Zheng, Ling Pan, Ting Niu

    Published 2024-09-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 166
    Tandem Versus Single Autologous Stem Cell Transplantation for High‐Risk Multiple Myeloma in the Era of Novel Agents: A Real‐World Study of China

    Tandem Versus Single Autologous Stem Cell Transplantation for High‐Risk Multiple Myeloma in the Era of Novel Agents: A Real‐World Study of China by Xuelin Dou, Juan Ren, Jiangtao Li, Xiaodan Liu, Li Bao, Yuan Chen, Peng Zhao, Yuping Zhong, Nan Peng, Lei Wen, Leqing Cao, Yang Liu, Daoxing Deng, Fengrong Wang, Liru Wang, Hui Liu, Xiaojun Huang, Xiaodong Mo, Jin Lu

    Published 2025-01-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 167
    Prognostic Implications of the Number of Lymph Node Metastases in Oral Tongue Squamous Cell Carcinoma: A Population Study of the SEER Database and an Institutional Registry

    Prognostic Implications of the Number of Lymph Node Metastases in Oral Tongue Squamous Cell Carcinoma: A Population Study of the SEER Database and an Institutional Registry by Wenjie Huang, Yu Zhang, Hao Li, Zhiying Liang, Shumin Zhou, Jie Pan, Hui Xie, Chao Luo, Shuqi Li, Guangying Ruan, Fei Ai, Yanfeng Chen

    Published 2024-12-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 168
    Cardiovascular and Metabolic Adverse Events of Endocrine Therapies in Women with Breast Cancer: A Disproportionality Analysis of Reports in the FDA Adverse Event Reporting System

    Cardiovascular and Metabolic Adverse Events of Endocrine Therapies in Women with Breast Cancer: A Disproportionality Analysis of Reports in the FDA Adverse Event Reporting System by Shaimaa Elshafie, Lorenzo Villa‐Zapata, Randall L. Tackett, Iman Y. Zaghloul, Henry N. Young

    Published 2025-01-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 169
    Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract

    Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract by Mohammad Jad Moussa, Georges C. Tabet, Arlene O. Siefker‐Radtke, Lianchun Xiao, Nathaniel R. Wilson, Jianjun Gao, Christopher J. Logothetis, Petros Grivas, Byron Lee, Amishi Y. Shah, Pavlos Msaouel, Roger Li, Leticia Campos Clemente, Jianping Zhao, Nizar M. Tannir, Ashish M. Kamat, Donna E. Hansel, Charles C. Guo, Matthew T. Campbell, Omar Alhalabi

    Published 2025-01-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 170
    Role of postoperative radiotherapy in pT3N0 rectal cancer: A risk‐stratification system based on population analyses

    Role of postoperative radiotherapy in pT3N0 rectal cancer: A risk‐stratification system based on population analyses by Yun‐xia Huang, Yan‐zong Lin, Jin‐luan Li, Xue‐qing Zhang, Li‐rui Tang, Qing‐yang Zhuang, Fei‐fei Lin, Xi‐jin Lin, Jun‐xin Wu

    Published 2019-03-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 171
    Cancer Incidence Among People With a Prior Hospital Record of Depression in Scotland, 1991–2019: A Cohort Study

    Cancer Incidence Among People With a Prior Hospital Record of Depression in Scotland, 1991–2019: A Cohort Study by Thulani Ashcroft, Kelly Fleetwood, Christine Campbell, Caroline A. Jackson

    Published 2025-01-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 172
    Statistical Fragility of Findings From Randomized Phase 3 Trials in Pediatric Oncology

    Statistical Fragility of Findings From Randomized Phase 3 Trials in Pediatric Oncology by Hannah E. Olsen, Pei‐Chi Kao, Caleb Richmond, David S. Shulman, Wendy B. London, Steven G. DuBois

    Published 2024-12-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 173
    Effectiveness of mobile health for exercise promotion on cardiorespiratory fitness after a cancer diagnosis: A systematic review and meta‐analysis

    Effectiveness of mobile health for exercise promotion on cardiorespiratory fitness after a cancer diagnosis: A systematic review and meta‐analysis by Megan E. Gregory, Weidan Cao, Saurabh Rahurkar, Fadi Haroun, James C. Stock, Sanam M. Ghazi, Daniel Addison

    Published 2024-09-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 174
    YTHDF1 Regulates RELA m6A Modification and Activates the NF‐Kappa B Signaling Pathway to Promote the Mechanism of Gastric Cancer

    YTHDF1 Regulates RELA m6A Modification and Activates the NF‐Kappa B Signaling Pathway to Promote the Mechanism of Gastric Cancer by Yangyuan Huang, Shihao Liang, Liping Li, Qingyu Zeng, Bin Li

    Published 2025-01-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 175
    Neoadjuvant everolimus in renal angiomyolipoma with or without tuberous sclerosis complex: Results from a multicenter, retrospective study

    Neoadjuvant everolimus in renal angiomyolipoma with or without tuberous sclerosis complex: Results from a multicenter, retrospective study by Ruopeng Su, Tingxuan Huang, Liangyou Gu, Yige Bao, Zhihong Liu, Pinghong Dao, Lin Yao, Xiaoyi Hu, Guanghou Fu, Jitao Wu, Thibault Tricard, Guangyu Wu, Minfeng Chen, Chancan Li, Zhiyang Huang, Bing Zheng, Yonghui Chen, Wei Xue, Gang Guo, Pei Dong, Jiwei Huang, Jin Zhang

    Published 2024-09-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 176
    Metagenomic Profiling of Oral Microbiome Dynamics During Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Patients

    Metagenomic Profiling of Oral Microbiome Dynamics During Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Patients by Dominique A. Torozan, Cédric Christian Laczny, Kirsten Roomp, Paul Wilmes, Jochen Fleckenstein, Jochen G. Schneider

    Published 2025-01-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 177
    Preservation of cfRNA in cytological supernatants for cfDNA & cfRNA double detection in non‐small cell lung cancer patients

    Preservation of cfRNA in cytological supernatants for cfDNA & cfRNA double detection in non‐small cell lung cancer patients by Yidan Ma, Yifei Wang, Lei He, Jun Du, Lin Li, Zhixin Bie, Yuanming Li, Xiaomao Xu, Wei Zhou, Xiaonan Wu, Li Yang, Jing Di, Chenyang Li, Xiaoguang Li, Dongge Liu, Zheng Wang

    Published 2024-09-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 178
    Feasibility of implementing a decision aid for advanced cancer patients in a comprehensive cancer centers' outpatient setting: Valuable lessons learned

    Feasibility of implementing a decision aid for advanced cancer patients in a comprehensive cancer centers' outpatient setting: Valuable lessons learned by K. Laryionava, R. Boekels, J. Schildmann, M. Wensing, U. Wedding, B. Surmann, K. Mehlis, C. Gebel, M. Cinci, K. Krug, E. C. Winkler

    Published 2024-12-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 179
    The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta‐analysis

    The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta‐analysis by Wenli Xie, Li Xie, Xianrang Song

    Published 2019-03-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 180
    Inhibitory Effect of PRMT5/MTA Inhibitor on MTAP‐Deficient Glioma May Be Influenced by Surrounding Normal Cells

    Inhibitory Effect of PRMT5/MTA Inhibitor on MTAP‐Deficient Glioma May Be Influenced by Surrounding Normal Cells by Yunjie Wang, Xiaohui Sun, Runchen Ma, Xiaofan Zhang, Shengmin Ji, Zhaofeng Liu, Gangqiang Yang, Hongbo Wang, Peng Zhang, Jianzhao Zhang, Jingwei Tian

    Published 2024-12-01
    “…Cancer Medicine…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: